Levalbuterol Solution
Product Images NDC 76204-700

Product Visual Gallery

This gallery contains 24 technical images submitted to the FDA as part of the official labeling for Levalbuterol (NDC 76204-700). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ritedose Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

25 Ct Cards Carton (Rpsc0189 0.31mg 25 Ct Cards Carton)

Packaging label for Levalbuterol Inhalation Solution, USP, 0.31 mg/3 mL, by Ritedose Pharmaceuticals, LLC. The label includes dosage strength, usage instructions for oral inhalation only, and barcodes. The design features green bands and text on a white background, with the NDC 76204-700-55.*

FDA Label Image

25 Ct Brick Carton (Rpsc0190 0.31mg 25 Ct Brick Carton)

Packaging label for Levalbuterol Inhalation Solution, USP 0.31 mg/3 mL by Ritedose Pharmaceuticals, LLC. The label includes dosage strength (0.31 mg/3 mL), administration route (inhalation), and manufacturer details. The label also features barcodes and patient storage instructions.*

FDA Label Image

25 Ct Cards Carton (Rpsc0193 0.63mg 25 Ct Cards Carton)

Packaging label for Levalbuterol Inhalation Solution, USP 0.63 mg/3 mL by Ritedose Pharmaceuticals, LLC. The label shows the drug concentration, dosing form as solution for oral inhalation only, and instructions on the packaging. It includes barcodes, the NDC number 76204-800-55, and the Ritedose logo. The label indicates a package size of 25 single-dose vials of 3 mL each.*

FDA Label Image

25 Ct Brick Carton (Rpsc0194 0.63mg 25 Ct Brick Carton)

Packaging label for Levalbuterol Inhalation Solution, USP 0.63 mg/3 mL by Ritedose Pharmaceuticals, LLC. The label details the product strength, formulation as an inhalation solution, and includes manufacturer information. It also displays storage instructions, cautions for pharmacists, and the NDC number 76204-800-25. The design uses white and orange colors with printed text.*

FDA Label Image

25 Ct Cards Carton (Rpsc0197 1.25mg 25 Ct Cards Carton)

Packaging label for Levalbuterol Inhalation Solution, USP 1.25 mg/3 mL by Ritedose Pharmaceuticals, LLC. The label includes the proprietary and generic names, strength, dosage form as a respiratory inhalation solution, and directions specifying for oral inhalation only. The package design uses red and white colors and features the NDC number 76204-900-55 along with barcodes and manufacturer information.*

FDA Label Image

25 Ct Brick Carton (Rpsc0198 1.25 mg 25 Ct Brick Carton)

Levalbuterol Inhalation Solution, USP 1.25 mg/3 mL packaged in a carton with red and white design elements. The label includes strength information (1.25 mg, 0.042%), barcode, manufacturer details (Ritedose Pharmaceuticals, LLC), and storage instructions. The label indicates the product is for respiratory inhalation and contains 25 x 3 mL unit-dose vials. The NDC number 76204-900-25 is visible on the packaging.*

FDA Label Image

30 Ct Singles Carton (Rpsc0290 0.31mg 30 Ct Singles Carton)

Levalbuterol Inhalation Solution, USP 0.31 mg/3 mL carton for respiratory inhalation use. The package indicates Levalbuterol Hydrochloride at a strength of 0.31 mg per 3 mL solution. It is labeled for oral inhalation only and includes a barcode and the Ritedose Pharmaceuticals, LLC logo. The label displays the National Drug Code (NDC) 76204-700-01 and shows a pictogram of a single-dose vial on a green background.*

FDA Label Image

30 Ct Singles Carton (Rpsc0291 0.63mg 30 Ct Singles Carton)

Flat layout of packaging for Levalbuterol Inhalation Solution, USP 0.63 mg/3 mL by Ritedose Pharmaceuticals, LLC. The carton includes the product name, strength, and usage indication for oral inhalation only. It features barcode, NDC number 76204-800-01, and an illustration of a single-dose vial. The design includes orange highlights and the Ritedose Pharmaceuticals logo in blue.*

FDA Label Image

30 Ct Singles Carton (Rpsc0292 1.25mg 30 Ct Singles Carton)

Levalbuterol Inhalation Solution, USP 1.25 mg/3 mL carton packaging from Ritedose Pharmaceuticals, LLC. The label shows the drug name, strength, dosage form as inhalation solution, and instructions for oral inhalation use. The packaging includes a barcode and the NDC number 76204-900-01, with multiple panels displaying product and manufacturer information.*

FDA Label Image

Chemical Structure (Levalbuterol 01)

Chemical structure of Levalbuterol Hydrochloride showing its molecular arrangement with hydroxyl groups and an amine group associated with the hydrochloride portion.*

FDA Label Image

Figure 1 (Levalbuterol 02)

A line graph depicting mean change in FEV1 (forced expiratory volume) over 8 hours for various doses of Levalbuterol (Lev) and Racemic albuterol (Rac), compared to placebo (PBO). The x-axis represents time in hours, and the y-axis shows mean change in FEV1 (%). Multiple lines show different patient groups or doses as indicated by symbols in the legend.*

FDA Label Image

Figure 2 (Levalbuterol 03)

A line graph showing mean change in FEV1 (%) over 8 hours for different doses of Levalbuterol (0.63 mg and 1.25 mg), Rac 2.5 mg, and placebo (PBO). The graph illustrates changes from baseline over time with separate lines and symbols for each treatment group.*

FDA Label Image

Figure 3 (Levalbuterol 04)

Line graph showing mean change in FEV1 (%) over time (hours) for different treatments: Levalbuterol 0.63 mg, Levalbuterol 0.31 mg, Racemic albuterol 2.5 mg and 1.25 mg, and placebo (Pbo). The graph compares respiratory response over a 4-hour period for sample sizes ranging from 59 to 67 per treatment group.*

FDA Label Image

Figure 4 (Levalbuterol 05)

A line graph showing the mean change in FEV1 (%) over time (hours) comparing different doses of Levalbuterol (0.31 mg and 0.63 mg), Racemic Albuterol (1.25 mg and 2.5 mg), and placebo. The graph includes multiple data points up to 4 hours, depicting the respiratory drug’s effect on lung function with distinct markers for each group.*

FDA Label Image

Figure A (Levalbuterol 06)

An instructional diagram showing a unit-dose vial with shaded twist-off tab areas on both sides of the top portion. Labels indicate these shaded regions as the twist-off tab portion of the vial, demonstrating where to twist off for opening.*

FDA Label Image

Figure B (Levalbuterol 07)

An instructional illustration showing the top portion of a pouch with an arrow and text indicating to 'TEAR AT SEAM' for opening the package. The image highlights the tearable seam at the top edge of the pouch.*

FDA Label Image

Figure C (Levalbuterol 08)

Illustration showing hands opening a single-dose vial or ampule by twisting or snapping the top, indicated by an arrow pointing to the right. The image likely demonstrates part of the preparation or usage instructions for a respiratory inhalation solution.*

FDA Label Image

Figure D (Levalbuterol 09)

An instructional illustration showing a hand holding a vial above a labeled reservoir. The vial is depicted as being positioned to dispense its contents into the reservoir, highlighting the components labeled as 'VIAL' and 'RESERVOIR.' The image is likely related to the preparation or use of an inhalation solution.*

FDA Label Image

Figure E1 (Levalbuterol 10)

An instructional illustration showing parts of a respiratory inhalation device for Levalbuterol solution. The image highlights the mouthpiece and the reservoir components of the device, used for administering the medication by inhalation.*

FDA Label Image

Figure E2 (Levalbuterol 11)

An instructional illustration showing a face mask connected to a reservoir. The diagram labels the 'FACE MASK' and 'RESERVOIR' components, likely related to the use of a respiratory inhalation device for administering medication.*

FDA Label Image

Figure F (Levalbuterol 12)

An instructional diagram illustrating the connection of nebulizer tubing to a compressor device, labeled accordingly. The image shows a rectangular compressor unit with a knob and display area, and a tube labeled 'NEBULIZER TUBING' attached to it.*

FDA Label Image

Figure G1 (Levalbuterol 13)

An instructional diagram illustrating the correct use of a respiratory inhalation device, showing a person placing the mouthpiece into their mouth with the reservoir connecting to the device.*

FDA Label Image

Figure G2 (Levalbuterol 14b)

An instructional diagram showing a face mask attachment connected to a reservoir and a medication vial, illustrating the setup for administering a respiratory inhalation solution with Levalbuterol.*

FDA Label Image

Rdp Logo (Rdp Logo)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.